- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myotonic Dystrophy Type 2 in France
Total 670 results
-
PhenomixTerminatedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, India
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingRecurrent IDH1/2 Mutated GliomaFrance
-
Novo Nordisk A/SRecruitingType 2 Diabetes MellitusKorea, Republic of, United States, Hungary, Serbia, Spain, China, Australia, Finland, United Kingdom, Italy, Denmark, Canada, Taiwan, Poland, Germany, Sweden, South Africa, India, Argentina, Brazil, Bulgaria, Japan, Mexico, Turkey, Greece, Colomb... and more
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Chile, Czech Republic, Denmark, France, Germany, Hungary, Lithuania, Mexico, Poland, Romania, Slovakia, Sweden
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusFrance, Italy, Turkey, Germany, United Kingdom, Belgium, Spain
-
PhenomixUnknownType 2 Diabetes MellitusUnited States, Argentina, Canada, India, Mexico
-
Nantes University HospitalUniversity Hospital, AngersRecruiting
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, France, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, United States, Argentina, Brazil, Canada
-
Jiangsu HengRui Medicine Co., Ltd.CompletedType 2 DiabetesAustralia, China, United States
-
AstraZenecaCompletedType 2 DiabetesUnited States
-
Institut National de la Santé Et de la Recherche...Biogen; Ionis Pharmaceuticals, Inc.CompletedSpinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 7France
-
University Hospital, CaenRecruitingVon Willebrand Disease, Type 2BFrance
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Canada, Mexico, Guatemala, Germany, Brazil, Puerto Rico, Costa Rica
-
Akros Pharma Inc.CompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaTerminatedType 2 DiabetesCzech Republic, France, Poland, Philippines, Estonia, Latvia, Lithuania, Norway, Hungary, Slovakia, Greece, Sweden, Australia, Former Serbia and Montenegro
-
AstraZenecaTerminatedType 2 DiabetesFrance, Korea, Republic of, South Africa, Spain, United Kingdom, Vietnam, Norway, Israel, Philippines, Australia
-
TakedaCompletedType 2 Diabetes MellitusUnited States, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Guatemala, India, Israel, Latvia, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, South Africa, Ukraine
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSweden, France, Italy, Mexico, South Africa, Spain, Germany, Netherlands, Argentina, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United Kingdom, Australia, Canada, Thailand, India
-
SanofiCompletedType 2 Diabetes MellitusSpain, United States, Canada, Czech Republic, France, Germany, Poland, Romania, Russian Federation, Ukraine
-
Lexicon PharmaceuticalsSanofiTerminatedHeart Failure | Type 2 Diabetes MellitusBelgium, Canada, Israel, Spain, Germany, Argentina, Chile, Hungary, Korea, Republic of, Latvia, Lithuania, Russian Federation, Sweden, Romania, Poland, Brazil, Denmark, United States, Australia, Austria, Czechia, Finland, France, Greece, Ita... and more
-
Arizona State UniversityTakeda Pharmaceuticals North America, Inc.UnknownType II Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, South Africa, Norway, Argentina, Belgium, Denmark, Sweden, France, Italy
-
Boehringer IngelheimCompletedHypertension | Diabetes Mellitus, Type 2Germany, France, Spain
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Canada
-
Centre Hospitalier Universitaire DijonCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSpain, Germany, France, United Kingdom
-
Centre Hospitalier Régional d'OrléansCompletedMultiple Sclerosis | Cancer | Hiv | Hypergammaglobulinemia | Hematologic Malignancy | Myeloma | Malignant Tumor | Diabetes Type 2 | Kidney TransplantFrance
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Italy, Hong Kong, Romania, Greece, United States, Mexico, Serbia, Russian Federation
-
SanofiCompletedType 2 Diabetes MellitusUnited States, South Africa, Canada, Czechia, Estonia, Finland, France, Germany, Hungary, Latvia, Mexico, Netherlands, Romania
-
University Hospital, MontpellierCompletedInduction of Labour | Macrosomia | Non-insulin-dependent DiabetesFrance
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
University Hospital, Strasbourg, FranceTerminatedType 2 Diabetes | Silent Myocardial IschemiaFrance
-
Assistance Publique Hopitaux De MarseilleCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Puerto Rico
-
CymaBay Therapeutics, Inc.CompletedType 2 DiabetesUnited States, Israel, Argentina, India
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2France, United States, Mexico, United Kingdom, Spain, Canada, New Zealand, Thailand, Russian Federation, Brazil, Germany, Australia, Poland, Slovakia, Peru, Ukraine, South Africa, Costa Rica, Puerto Rico
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czechia, France, Hungary, Slovakia, United Kingdom
-
Elcelyx Therapeutics, Inc.CompletedType 2 Diabetes MellitusUnited States, Puerto Rico
-
Assistance Publique - Hôpitaux de ParisCompletedSpinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia, Autosomal Recessive 3 | Episodic Ataxia, Type 7France
-
PfizerTerminatedDiabetes Mellitus Type 2Spain, Canada, France, Greece, Portugal, Sweden, Turkey
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States, Puerto Rico
-
Hospices Civils de LyonUnknown
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2France, Poland, United Kingdom, United States, Spain, Colombia, India, Romania, South Africa, Ukraine, Australia, Canada, Greece, Sweden, New Zealand, Switzerland, Hong Kong
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Germany, Puerto Rico, Hungary, Spain, Poland, Mexico, Romania, Slovakia, Czech Republic
-
SanofiTerminated
-
GlaxoSmithKlinePPDCompletedDiabetes Mellitus, Type 2Spain, Germany, Hungary, Italy, Philippines, France, United States, Mexico, Brazil, South Africa, Korea, Republic of, Canada, Poland, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, United States, Australia, Brazil, Czech Republic, Italy, Mexico, Peru, Poland, Russian Federation, South Africa, Spain, United Kingdom, Germany, China, Hungary, Netherlands, Canada, Hong Kong, Argentina, Chile, France, Israel, Puerto Rico and more
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Dominican Republic, Chile